Insights from ASCO ‘24: Harnessing AI for Better Cancer Treatment Outcomes

Dane Lund
Medical Strategist

As a medical strategist, Dane brings extensive oncology experience across lung, breast, prostate, gastric, and liquid tumors as well as expertise in rare diseases, autoimmune disease, and genetic testing. He has contributed to the growth of brands like Enhertu, Verzenio, Calquence, Tepezza, Tyvyt, Invitae, Giapreza, And Lumryz. Dane is passionate about making science accessible for patients and healthcare providers through creative deliverables. He has developed and launched multiple campaigns, messaging platforms, and product theaters. Dane holds a BS and PhD from the University of Missouri and completed a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center, where he studied cancer-related muscle wasting and developed AI-based drug-screening assays.

Marina Oraczewski
VP, Medical Strategy

Marina brings over a decade of experience in medical strategy, brand development, and medical communications across oncology, immunology, and rare diseases. She has shaped brands within Genentech’s HER2+ breast cancer franchise and contributed to the launches of Lenvima for solid tumors and Gavreto for RET+ cancers. As a brand strategist, she developed pre-launch strategies for Genentech’s anti-TIGIT therapy and Pfizer’s cancer pain treatment. Marina holds a BSE in chemical engineering from the University of Pennsylvania, and completed her PhD in molecular biology from Princeton University, with her doctoral research dedicated to advancing the understanding of cell cycle control in cancer.

Jorge Durand
Executive Director, Medical Strategy

With over 15 years of medical strategy experience, Jorge has helped build healthcare brands across oncology, immunology, rare disease, and more. He is passionate about practice-changing ideas grounded in deep scientific and market analysis, especially for brands significantly impacting the lives of patients.. He’s led marketing and medical affairs efforts, helped develop new messaging platforms and campaigns, optimized omnichannel strategy, and collaborated with thought leaders and patient-advocate organizations. Since joining Klick in 2017, Jorge has expanded the medical strategy department tenfold and grown the overall brand portfolio. He holds a BS and an MS in nuclear engineering from Balseiro Institute and a PhD/MS in biomedical sciences from Albert Einstein College of Medicine.